OPIANT PHARMACEUTICALS, INC.
DelistedCIK 1385508fmd_0AH7QK19GRDQ9P5CE94MQ1ZN98Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Aug 01, 2005 to Sep 30, 2022, 58 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 2 | 10 | 18 | – | 14 | 41 | 30 | 48 |
| Total interest income | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Net interest income | – | – | (0) | (0) | 0 | – | 0 | 0 | (0) | (2) |
| Cost of revenue | – | – | – | – | – | – | 14 | 0 | – | – |
| Gross profit | – | – | – | – | – | – | 0 | 41 | – | – |
| Research and development | 0 | 0 | 2 | 3 | – | 5 | 8 | 9 | 9 | 17 |
| Selling, general and administrative | – | – | – | – | – | – | 11 | 13 | 16 | 17 |
| Total operating expenses | 9 | 11 | 8 | 18 | – | 17 | 35 | 30 | 32 | 43 |
| Operating income | (9) | (11) | (7) | (8) | – | (2) | (21) | 11 | (2) | 5 |
| Interest expense | 1 | 0 | 0 | – | – | – | – | 0 | 0 | 2 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | – | 0 | 0 | 1 | (0) | (2) |
| Income before taxes | (9) | (11) | (7) | (8) | – | (2) | (21) | 11 | (2) | 3 |
| Income tax expense | – | – | 0 | 0 | – | 1 | 0 | (0) | (0) | 0 |
| Net income from continuing operations | – | – | (7) | (8) | – | (3) | (21) | 12 | (2) | 3 |
| Net income | (9) | (11) | (7) | (8) | – | (3) | (21) | 12 | (2) | 3 |